From Vanguard Group acquiring the sale of its scrapped East Coast campus, to completing the sale of its U.K. companies, here are eight updates on Centene that Becker's has reported since Feb. 6:
The Latest
CMS finalized several proposed changes to regulations for the ACA marketplace in 2025.
CMS has finalized a slight decrease in Medicare Advantage benchmark payments for 2025, despite large insurers reporting rising costs and utilization among MA members.
Aetna has named Ali Khan, MD, as chief medical officer for Medicare and dual-eligible beneficiaries.
Investment income drove a $377 million net income for Independence Blue Cross in 2023.
Cigna and Toledo, Ohio-based ProMedica are out of network as of April 1.
Investment advisory firm Vanguard Group is acquiring the Charlotte, N.C.-based office campus that was once planned to be Centene's East Coast headquarters, the Charlotte Business Journal reported April 2.
Medicare total spending hit $5.7 billion in 2022 after rebates for GLP-1 drugs such as Ozempic, Wegovy and Mounjaro, up from $57 million in 2018, according to a March 22 KFF analysis.
A federal judge has ruled that the Blue Cross Blue Shield Association and BCBS Michigan must face a lawsuit from Ford Motor Co. over an alleged antitrust conspiracy among Blues plans to fix healthcare prices, thereby overcharging Ford for health…
Wegovy was approved in March to reduce the risk of heart attack and stroke in adults with heart disease, paving the way for Medicare coverage of weight loss drugs. Now, healthcare policy experts anticipate monthly premiums for millions of Medicare…